Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C17H10F3N3O3S2 |
| Molecular Weight | 425.405 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
OC(=O)CC1=NN(CC2=NC3=C(S2)C=CC(=C3)C(F)(F)F)C(=O)C4=CSC=C14
InChI
InChIKey=ORQGHAJIWGGFJK-UHFFFAOYSA-N
InChI=1S/C17H10F3N3O3S2/c18-17(19,20)8-1-2-13-12(3-8)21-14(28-13)5-23-16(26)10-7-27-6-9(10)11(22-23)4-15(24)25/h1-3,6-7H,4-5H2,(H,24,25)
| Molecular Formula | C17H10F3N3O3S2 |
| Molecular Weight | 425.405 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
Approval Year
| Substance Class |
Chemical
Created
by
admin
on
Edited
Wed Apr 02 00:38:06 GMT 2025
by
admin
on
Wed Apr 02 00:38:06 GMT 2025
|
| Record UNII |
6JLQ8K35KK
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Official Name | English | ||
|
Systematic Name | English | ||
|
Code | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
FDA ORPHAN DRUG |
685219
Created by
admin on Wed Apr 02 00:38:06 GMT 2025 , Edited by admin on Wed Apr 02 00:38:06 GMT 2025
|
||
|
FDA ORPHAN DRUG |
777720
Created by
admin on Wed Apr 02 00:38:06 GMT 2025 , Edited by admin on Wed Apr 02 00:38:06 GMT 2025
|
||
|
FDA ORPHAN DRUG |
765620
Created by
admin on Wed Apr 02 00:38:06 GMT 2025 , Edited by admin on Wed Apr 02 00:38:06 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
KL-74
Created by
admin on Wed Apr 02 00:38:06 GMT 2025 , Edited by admin on Wed Apr 02 00:38:06 GMT 2025
|
PRIMARY | |||
|
11608
Created by
admin on Wed Apr 02 00:38:06 GMT 2025 , Edited by admin on Wed Apr 02 00:38:06 GMT 2025
|
PRIMARY | INN | ||
|
132260161
Created by
admin on Wed Apr 02 00:38:06 GMT 2025 , Edited by admin on Wed Apr 02 00:38:06 GMT 2025
|
PRIMARY | |||
|
2170729-29-8
Created by
admin on Wed Apr 02 00:38:06 GMT 2025 , Edited by admin on Wed Apr 02 00:38:06 GMT 2025
|
PRIMARY | |||
|
300000020992
Created by
admin on Wed Apr 02 00:38:06 GMT 2025 , Edited by admin on Wed Apr 02 00:38:06 GMT 2025
|
PRIMARY | |||
|
C179088
Created by
admin on Wed Apr 02 00:38:06 GMT 2025 , Edited by admin on Wed Apr 02 00:38:06 GMT 2025
|
PRIMARY | |||
|
6JLQ8K35KK
Created by
admin on Wed Apr 02 00:38:06 GMT 2025 , Edited by admin on Wed Apr 02 00:38:06 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
TARGET -> INHIBITOR |
Reduces toxic galactitol levels and prevents disease complications in GALT deficiency. Brain penetrant.
IC50
|
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |
|
| Name | Property Type | Amount | Referenced Substance | Defining | Parameters | References |
|---|---|---|---|---|---|---|
| BRAIN/PLASMA RATIO | PHARMACOKINETIC |
|
|
|||